Effects of the optical isomers of the narcotic antagonist analgesic pentazocine on brain and heart biogenic amines.
D000818:Animals; D001679:Biogenic Amines / Q000037:antagonists & inhibitors / Q000378:metabolism*; D001921:Brain / Q000201:enzymology; D001923:Brain Chemistry / Q000187:drug effects*; D001933:Brain Stem / Q000378:metabolism; D002250:Carbon Radioisotopes; D002540:Cerebral Cortex / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005470:Fluorometry; D006321:Heart / Q000187:drug effects*; D007536:Isomerism; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism; D010293:Pargyline / Q000494:pharmacology; D010423:Pentazocine / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013997:Time Factors; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D001679:Biogenic Amines; D002250:Carbon Radioisotopes; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D010293:Pargyline; D014446:Tyrosine 3-Monooxygenase; D010423:Pentazocine; D004298:Dopamine; D009638:Norepinephrine